Friday, September 3, 2010

US breast cancer drug decision ‘marks start of death panels’

August 17, 2010 by Brendan Joseph  
Filed under World News


Telegraph | A decision to rescind endorsement of the drug would reignite the debate over US health care reform and how much the state should spend on new and expensive treatments.

Ahmadinejad Calls For TV Debate With Obama

August 2, 2010 by Jose Luis Flores  
Filed under Media


August 2nd, 2010 Reuters By: Robin Pomeroy Iranian President Mahmoud Ahmadinejad called on U.S. President Barack Obama on Monday to face him in a televised one-on-one debate to see who has the best solutions for the world’s problems. The provocative proposal comes as Iran deals with a new wave of international sanctions — driven

9/11 First Responders Bill Fails In House

August 1, 2010 by Gia Zavala  
Filed under Media


July 30, 2010 WCBSTV.com by Sean Hennessey The topic of 9/11 was the center of an emotional storm on Thursday — this time in Washington, D.C. — as lawmakers debated healthcare funding for responders. And has CBS 2 HD witnessed, the most heated moments were between two respected members of New York’s delegation. During the debate over healthcare for 9/11

90 percent of scientists backing Avandia diabetes drug had financial ties to drug companies

July 23, 2010 by Jose Luis Flores  
Filed under Health


(NaturalNews) More than 90 percent of researchers who have published studies favorable to the controversial diabetes drug Avandia had a financial stake in the issue, according to a study conducted by researchers from the Mayo Clinic. The Mayo Clinic is one of the few research organizations in the United States that does not accept corporate funding. Sales of GlaxoSmithKline’s bestselling drug Avandia plunged in 2007, after evidence emerged linking the drug to an increased risk of heart attack and death. These reports sparked a debate over the drug’s safety that continues to this day. In an analysis of more than 200 studies, articles, editorials and letters published in scientific journals since 2007, Mayo Clinic researchers have concluded that financial conflict of interest continues to play a major role in that debate. Fully 87 percent of all authors who expressed positive views about Avandia had financial ties to GlaxoSmithKline, while another 7 percent had ties to other pharmaceutical companies involved with diabetes. Among authors with financial conflicts of interest, only 30 percent “expressed unfavorable views” of the drug. In contrast, authors who were critical of …

Obama confronts heated immigration issue in meeting with Arizona governor

June 4, 2010 by Orion Christopher  
Filed under World News


Canadian Free Press | Obama confronted the country’s raging immigration debate in a meeting with Arizona’s conservative Republican governor, who says she gave no ground on the explosive political issue.

Bill Clinton Sees ‘More Immigrants’ As A Way To Reduce Deficit

April 29, 2010 by Mabel Ray  
Filed under World News


Huffington Post | Clinton enthusiastically weighed into the blistering national debate on immigration today with a resounding assertion that America needs more immigrants.

In Denial

March 13, 2010 by Mabel Ray  
Filed under World News


The Meltdown of the Climate Campaign By Steven F. Hayward It is increasingly clear that the leak of the internal emails and documents of the Climate Research Unit at the University of East Anglia in November has done for the climate change debate what the Pentagon Papers did for the Vietnam war debate 40 years ago-changed the narrative decisively. Additional revelations of unethical behavior, errors, and serial exaggeration in climate science are rolling out on an almost daily basis, and there is good reason to expect more. The U.N.’s Intergovernmental Panel on Climate Change (IPCC), hitherto the gold standard in climate science, is under fire for shoddy work and facing calls for a serious shakeup. The U.S. Climate Action Partnership, the self-serving coalition of environmentalists and big business hoping to create a carbon cartel, is falling apart in the wake of the collapse of any prospect of enacting cap and trade in Congress. Meanwhile, the climate campaign’s fallback plan…

81% of America Favor Legalizing Medical Marijuana

January 19, 2010 by Jose Luis Flores  
Filed under Media


January 19, 2010 The Raw Story By Stephen C. Webster The medical marijuana debate among American voters is over. Eight in 10 Americans — 81% overall — support allowing doctors to prescribe cannabis, according to an ABC News/Washington Post poll. That’s up from just 69% in 1997, the last time the two firms asked that question, and from 75% in

Game Changer: Debra Medina Leading in the Texas Gov. Polls?

January 18, 2010 by Jose Luis Flores  
Filed under World News


Johnny Alamo | A funny thing happened on the way back from the Debate Thursday night.

Obama Pays Leading Economist to Support Health Care

January 12, 2010 by Brendan Joseph  
Filed under World News


Jane Hamsher Infowars.com January 12, 2010 For almost the entirety of the health care debate, the Obama Administration has relied on economist Jonathan Gruber to make the public case for its idea of reform – even the most unpopular parts. But as Firedoglake revealed on Friday , the Obama Administration has failed to disclose that it paid the same economist more than $780,000. Jonathan Gruber’s work has been cited by the White House, Members of Congress, and countless media outlets, but not once did the Obama Administration disclose it was paying him more than $780,000 in tax dollars. This is a huge ethical violation that undermines the entirety of health care reform. Sign our petition to President Obama: come clean on Jonathan Gruber and anyone else receiving public money to push health care reform. http://action.firedoglake.com/gruber Once we broke this scandal, The New York Times, Washington Post, Time Magazine , and other publications all said they should have disclosed Gruber’s lucrative contracts if they were aware of the conflict of interest. Dozens of Members …

Improve the web with Nofollow Reciprocity.